Pasireotide-induced hyperglycemia in a patient with Cushing's disease: Potential use of sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist for treatment.
Cushing's disease
diabetes mellitus
glucagon‐like peptide‐1 receptor agonist
pasireotide
sodium‐glucose cotransporter 2 inhibitor
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
21
03
2020
revised:
05
06
2020
accepted:
18
07
2020
entrez:
28
12
2020
pubmed:
29
12
2020
medline:
29
12
2020
Statut:
epublish
Résumé
Pasireotide improves hypercortisolemia and induces hyperglycemia via somatostatin receptor type-5 stimulation. GLP-1RA and SGLT2 inhibitor potentially help regulate hyperglycemia in patients with Cushing's disease, especially after pasireotide administration.
Identifiants
pubmed: 33363790
doi: 10.1002/ccr3.3230
pii: CCR33230
pmc: PMC7752440
doi:
Types de publication
Case Reports
Langues
eng
Pagination
2613-2618Informations de copyright
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
None declared.
Références
J Clin Endocrinol Metab. 2013 Aug;98(8):3446-53
pubmed: 23733372
Endocrine. 2018 Sep;61(3):473-481
pubmed: 29916102
Endocrinology. 2016 Mar;157(3):1029-42
pubmed: 26713783
Diabetes. 2017 May;66(5):1172-1184
pubmed: 28246292
Metabolism. 2011 Nov;60(11):1500-10
pubmed: 21864867
J Endocrinol Invest. 2018 Oct;41(10):1137-1147
pubmed: 29396758
J Clin Endocrinol Metab. 2019 Jun 1;104(6):1978-1988
pubmed: 30608534
Nat Clin Pract Endocrinol Metab. 2008 Oct;4(10):560-8
pubmed: 18711406
Eur J Pharmacol. 1998 Jan 12;341(2-3):257-63
pubmed: 9543247
Nat Commun. 2019 Jan 11;10(1):139
pubmed: 30635569
Diabetes Metab. 2017 Oct;43(5):411-415
pubmed: 28579289
Endocr Rev. 2013 Aug;34(4):525-55
pubmed: 23612224
Ther Clin Risk Manag. 2015 Mar 17;11:425-34
pubmed: 25834454
N Engl J Med. 2015 Nov 26;373(22):2117-28
pubmed: 26378978
Lancet Diabetes Endocrinol. 2018 Feb;6(2):105-113
pubmed: 29221659
Diabetes Care. 2018 Aug;41(8):1543-1556
pubmed: 30030256
Front Endocrinol (Lausanne). 2018 Jun 05;9:284
pubmed: 29915558
Clin Sci (Lond). 2015 Sep;129(5):405-14
pubmed: 25853863
Clin Biochem. 2014 Dec;47(18):279-82
pubmed: 25218816
Diabetes Res Clin Pract. 2014 Mar;103(3):458-65
pubmed: 24461109
Pituitary. 2014 Apr;17(2):180-6
pubmed: 23564338
N Engl J Med. 2012 Mar 8;366(10):914-24
pubmed: 22397653